Medicamen Biotech consolidated net profit rises 59.26% in the June 2025 quarter
(12 Aug 2025)

Back
Net profit of Medicamen Biotech rose 59.26% to Rs 2.15 crore in the quarter ended June 2025 as against Rs 1.35 crore during the previous quarter ended June 2024. Sales declined 0.02% to Rs 43.04 crore in the quarter ended June 2025 as against Rs 43.05 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales43.0443.05 0
OPM %10.737.99 -
PBDT3.933.33 18
PBT2.131.56 37
NP2.151.35 59

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew